The Use of A Small Molecule To Improve The Thermostability Of DNA Junctions by Shams, Arik
The University of Southern Mississippi 
The Aquila Digital Community 
Honors Theses Honors College 
Spring 5-2014 
The Use of A Small Molecule To Improve The Thermostability Of 
DNA Junctions 
Arik Shams 
University of Southern Mississippi 
Follow this and additional works at: https://aquila.usm.edu/honors_theses 
 Part of the Molecular Biology Commons 
Recommended Citation 
Shams, Arik, "The Use of A Small Molecule To Improve The Thermostability Of DNA Junctions" (2014). 
Honors Theses. 212. 
https://aquila.usm.edu/honors_theses/212 
This Honors College Thesis is brought to you for free and open access by the Honors College at The Aquila Digital 
Community. It has been accepted for inclusion in Honors Theses by an authorized administrator of The Aquila 




The University of Southern Mississippi 
 
THE USE OF A SMALL MOLECULE TO IMPROVE  







Submitted to the Honors College of  
The University of Southern Mississippi  
in Partial Fulfillment  
of the Requirements for the Degree of  
Bachelor of Science  















Anthony Bell, Ph.D., Thesis Adviser 












Sabine Heinhorst, Ph.D., Chair 

















 The short-term goal of this research project is to employ small molecules as a 
means to stabilize four-way DNA junctions (4WJs) composed of natural DNA and 
chimeric nucleic acids. The long-term goal of the project is utilizing the 4WJs as 
extracellular therapeutic inhibitors of DNA binding proteins [i.e. Histones and High 
Mobility Group Protein B (HMGB1b)]. A number of studies have shown that classical 
intracellular DNA-binding proteins have a variety of deleterious side-effects when 
present in the extracellular milieu. In order to develop a successful 4WJ therapeutic, we 
are focused on using modified nucleic acids to enhance the stability of the resulting 
4WJ. The nucleic acid of interest is PNA (peptide nucleic acid). PNA was selected 
because it is known to form DNA-PNA duplex/triplex structures with elevated thermo- 
and nuclease stability. 4WJs are prepared using fluorescently labeled DNA strands and a 
single PNA strand. Small molecules are currently being investigated as tools to 
potentially link the PNA-DNA strands to form 4WJs composed of multiple PNA strands. 
One molecule of interest is [Ru(bpy)2(dpp)PtCl2]Cl2. Electrophoretic mobility shift assays 
(EMSAs) have shown that stable 4WJs form in the presence of this molecule. The 
junctions were visualized using polyacrylamide gels. Circular dichroism studies will be 
employed to characterize the structural properties of hybrid of interest. Once a stable 
4WJ structure is identified, the hybrid was used to study binding and inhibition of 
HMGB1 in cell-based assays. 
Keywords: DNA junctions, Holliday junctions, high mobility group proteins, HMGB1, peptide 
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CHAPTER I – INTRODUCTION 
 
The purpose of my project is to use small molecules (with a molecular weight of 
300-600) to stabilize the formation of four-way DNA junctions, and subsequently use 
those junctions as an extracellular ligand against the proinflammatory cytokine HMGB1 
(High Mobility Group B1). DNA four-way junctions (4WJs) are also referred to as Holliday 
junctions. 4WJs are named after Robin Holliday who proposed that genetic 
recombination and repair events were mediated by four stands of DNA converging to 
form a junction1. Figure 1 displays a schematic of the role of 4WJs in recombination. 
Genetic recombination, the primary mechanism of genetic diversity in organisms, takes 
place when strands of DNA break and rejoin with other strands to produce new DNA 
strands consisting of new sequences of base pairs2. As illustrated in Figure 1, two 
double-stranded DNA duplexes are recombined to form two new duplexes of the DNA, 
composed of sections of both the original strands. The crossover region is called the 
DNA junction. The 4WJ is an intermediate structure, and is naturally unstable during 
genetic recombination3. At the end of recombination, each DNA junction is resolved by 
the action of enzymes and proteins. The resulting DNA strands are composed of 
portions of their original sequence and portions of the strand of DNA that it overlapped 
or combined with1,3. The short-term goal of my research project is to utilize small 
molecules as a means to stabilize immobilized 4WJs composed of natural (DNA) and 
synthetic nucleic acids such as peptide nucleic acids (PNAs). The long-term goal of the  





project is to utilize the resulting 4WJs as 
therapeutic inhibitors against the 
proinflammatory cytokine HMGB1.  HMGB1 
was originally discovered in the early 70’s.   
HMGB1 is a highly abundant (106 
copies per cell) protein found in almost all 
cells.  HMGB1 is composed of 215 amino 
acids4,5.  The protein possesses two DNA binding domains (the a-box and b-box) 
followed by stretch of aspartic acid and glutamic acid residues.  A schematic for HMGB1 
is displayed in Figure 3. HMGB1 is very unique in that it is classified as a “Moonlighting 
Protein”.  As the name suggests, the protein has two different functions.  HMGB1 can 
function inside of the cell, where it binds/bends DNA to promote transcription. HMGB1 
Figure 2: Open-x form of immobilized 4WJ J1, 
with the four component strands labeled 101, 
102, 103, and 104. The 101 strand is labeled 
with a fluorophore on the 3' end. 
Figure 1: Genetic Recombination with 4WJs 
[http://www.nature.com/cr/journal/v20/n6/images/cr201073f1.jpg] 
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can also function outside of the cell, where it binds to immune receptors, such as 
Receptors for Advanced Glycation Endproducts (RAGE) to mediate the production of 
leukocytes (i.e. amplify the proinflammatory immune response).   
The protein was originally classified as an architectural DNA-binding protein whose sole 
function was to bind and bend DNA4,6.  Later it was shown that the protein can be either 
actively or passively released from cells into the extracellular matrix where it may bind 
to immune receptors.  In its alternative capacity, HMGB1 binding offers homeostatic 
benefits such as wound healing, dendrite maturation and neurite outgrowth.  However, 
the abundance of the protein often presents a problem because large amounts of the 
protein is often present in the extracellular region where it then binds to trigger 
superfluous leukocyte production.  As a result, there is often a great deal of collateral 
damage to healthy cells and tissues.  Hence it is not surprising that HMGB1 has been 
linked to a myriad of disease states that include cancer, arthritis, atherosclerosis, lupus, 
and sepsis4. 
Figure 3: HMGB1. The domain structure is shown in (a), and a 3D schematic of the compact form is shown 
in equilibrium with the more open form in (b).
5 
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Our strategy to mediate the deleterious behavior of HMGB1 is centered on 
combining or reassigning the original function of the molecule.  The hypothesis is to 
reassign hybrid 4WJs to the extracellular matrix where they can act as competitive 
inhibitors that bind HMGB1.  The 4WJs will effectively sequester HMGB1 and prevent its 
interaction with immune receptors, an outcome that would eventually stop the 
production of leukocytes.  The premise for the strategy is based on the fact there is 
experimental data that clearly show that HMGB1 binds 4WJ and bent DNA with very 
high affinity7,8. This suggests that these nucleic acid ligands would effectively target 
HMGB1 extracellularly. One area of concern is the high likelihood that DNA junctions 
would be rapidly degraded in vivo.  To offset this, researchers at the University of 
Southern Mississippi have developed novel hybrid 4WJs composed of DNA and PNA 
(peptide nucleic acids).  PNAs are synthetic hybrids of nucleic acids (DNA and RNA) and 
peptides that have been shown to possess enhanced stability (both in vitro and in vivo) 
compared to conventional nucleic acids9,10. 
 Research10 has shown that 4WJs composed of single PNA strands can be 
synthesized, and that they form stable structures that are bound by HMGB1b and the 
DNA-binding protein, Histone H1 with high affinity. However, 4WJs composed of two 
PNA strands are less stable. In order to increase the stability of these chimeric 4WJs, a 
series of small molecules are currently being investigated. The structure of a fully-
formed compound/4WJ combination in vitro will be elucidated, and the resulting 
junction will be further tested for nuclease and thermal stability. 
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CHAPTER II – LITERATURE REVIEW 
 
High mobility group B1 protein (HMGB1) 
The target protein in this study is high mobility group box 1, or HMGB1. HMGB1 
is a small protein comprised of 215 amino acid residues. It is composed of two domains, 
the A box and the B box, with a short linker between the two, and a long (30 amino acid) 
acidic C-terminal tail5 (Figure 3). HMGB1 binds to the minor groove of DNA, and 
therefore the minor groove of Holliday junctions as well. As HMGB1 is bound tightly to 
chromatin within the cell, its release into the extracellular matrix is usually a result of 
necrosis (cell collapse and death due to damage or disease), although active release by 
apoptotic cells (cells programmed to die at the end of their life cycle) can also occur11,12. 
The cytokine activity of HMGB1 is mostly due to its binding with RAGE, or Receptor for 
Advanced Glycation End-products. RAGE is a receptor that activates the immune system 
when it interacts with cytokines such as HMGB14,12,13 (Figure 6).  
Intracellularly, HMGB1 is a DNA binding protein that favors bent DNA structures. 
On the extracellular level HMGB1 acts as a pro-inflammatory cytokine. The sequence 
specificity of HMGB1 to DNA junctions is relatively low, which is due to the fact that 
HMG1 proteins bind to DNA via contact with the minor groove of the junction rather 
than the major groove where most transcription factors usually tend to bind5,7. 




Figure 4: The nature of cell death determines the type of immune response. A) Necrosis is when the 
cell collapses due to damage or disease and all the cell’s internal components are released into the 
extracellular matrix. In (B), apoptosis is the programmed cell death that results from homeostasis, and 
is the destruction of the cell at the end of its life cycle. C) Secondary necrosis occurs when there is an 
error in recognizing apoptotic cell death and the result is pro-inflammatory, like that of (A).
4
 




Four-way DNA junctions (4WJ) are three-dimensional higher-order DNA 
structures that are intermediates for DNA recombination in the cell. They also act as 
substrates for protein binding14. Proteins that recognize and bind to 4WJ do so at the 
level of their tertiary structure. During recombination, two DNA oligonucleotides join 
together at a specific point, where one strand from each strand remains continuous in 
one axis, while the complementary strands of each DNA molecule fold at the point of 
joining of the two molecules1–3 (Figure 1). The basic structure of a 4WJ is outlined in 
Figure 5. In cells, the 4WJ undergoes branch migration via the activity of the RuvA 
protein complex3. The junction is eventually resolved by the action of exonucleases. 
 
  
Figure 5: The stacked X-structure of 
4WJ. The ribbon indicates the path of 
the backbones in the right-handed, 
antiparallel stacked X-structure. The 
two sides of the structure are not 
equivalent. One side (m) presents 
minor groove edges of the base-pairs 
at the point of strand exchange, while 
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4WJ has two major conformations, dependent on cation activity. In the absence 
of metal cations, 4WJ adopts an open, unfolded structure. Upon the addition of metal 
cations (most prominently magnesium ions), the double-stranded or duplex arms of the 
4WJ stack coaxially15,16.  This conformational isomer is referred to as the stacked-x 
structure (Figure 4). The reason for this is that DNA is a charged polyelectrolyte 
(polymers composed of repeating electrolytic units) that can induce repulsive 
interactions with metal cations1,2. Multiple studies have provided evidence for this 
observation. As displayed in Figure 5, the structure of stacked-x and open-x 4WJs are 
very dynamic.  At cation concentrations  0.1 mM the conformation of 4WJs can readily 
interchange between open-x and stacked-x.  The open-x isomer is denoted below in 
Figure 6 (open-x = b and stacked-x = c)17. Figure 7 shows another diagram for the two 
conformations of 4WJ. 
Figure 6: Structural forms of DNA Holliday junctions. a. The parallel stacked-X 
junction initially proposed by Holliday as the recombination intermediate 
(Holliday, 1964). b. The extended open- X form of a DNA junction. c. The 
antiparallel stacked-X junction does not allow for migration of the junction 
along the DNA strands. d. Model of the antiparallel stacked-X junction 
proposed from solution studies.
15
 
Duckett et al., 1988, copied from Khuu, et. al. J. Mol. Recognit. (2006) 
The use of a small molecule to improve the thermostability of DNA junctions 9 
9 
 
Immobilized 4WJs (Figure 2) were first synthesized by Seeman et. al. in 1983 
using an algorithm to generate nucleic acid sequences that form junctions with high 
fidelity and stability.18 The smallest reported 4WJ, which we label J1, has optimally high 
fidelity and thermal stability. With respect to stabilizing or “locking” 4WJ structures, 
Brogden et. al reported the formation of stabilized junction upon addition of a small 
molecule synthesized in vivo19. The prototypical compound was derived from a class of 
compounds called acridines. The molecule was designed to crossover the junction 
region and “bridge” the two DNA strands together. Electrophoretic studies showed that 
the DNA junction was greatly stabilized when bound to this molecule. Electron density 
maps of the resulting junction showed a marked increase in the crossover site of the 
Figure 7: Ribbon model of the right-handed, antiparallel stacked X-structure of the four-way DNA 
junction, observed from three points of view. Note the juxtaposition of the continuous strands in the 
major grooves of the opposing helices, which is optimal for a small angle of 600 for the helix crossing. 
Centre: face view, showing the X-shape of the folded junction: the two sides of the structure are not 
equivalent. On one side (left) the four basepairs at the point of strand exchange all present major 
groove edges, while on the other side (right) the minor groove edges are presented.
2 
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junction, which implies a stronger binding between the molecules present at that 
region. Another study by Howell and colleagues reported a similar experiment with 
another acridine derivative that behaved analogously to divalent cations such as 
magnesium and calcium to bind DNA junction and stabilizing it20. The acridine binds in 
an intercalative fashion to the DNA junction. They also found that a high temperature 
annealing step is still necessary even in the presence of high concentrations of cations to 
form the junction in vitro. 
Peptide nucleic acids (PNA) and DNA/PNA hybrids 
Peptide nucleic acid, or PNA, has a structure very similar to that of DNA, and in 
fact was designed as a DNA mimic that could recognize and bind to DNA21,22. The major 
difference is in the backbone of the two structures. DNA contains a phosphodiester 
backbone, PNA contains a pseudo-peptide backbone that also has the practical 
advantage of being neutral (Figure 8). 
One interesting and useful characteristic of PNA-DNA interactions is that the 
binding between PNA/DNA complexes is much stronger than that of typical DNA/DNA 
structures. Since the PNA molecule is uncharged, there is no charge repulsion between 
charged DNA and neutral PNA22 (Figure 6). Because of this feature, PNA/DNA complexes 
are more thermally stable, and more resistant to nucleases that (enzymes that cleave 
nucleic acids). One disadvantage to PNA, however, is its relatively lower solubility in 
water due to the neutral nature of of its peptide backbone. 
 




A report by Musumeci and colleagues8 describes the use of a PNA/DNA complex 
to bind HMGB1, with the aim of inhibiting cytokine activity. In the experiment, a double-
stranded PNA/DNA chimera was used to bind HMGB1 in vitro, with positive results. The 
concentration of HMGB1 in chemotaxis assays decreased with application of the 
PNA/DNA chimera. However, the double-stranded complex used in the experiment has 
only one binding site for HMGB1, compared to four in a DNA junction. In addition, the 
binding site for the protein consisted of solely DNA, whereas in a PNA/DNA 4WJ the 
binding sites include PNA as well. 
Figure 8: Comparison of DNA and PNA chemical structures. Shown here is a N-(2-amino-
ethyl)-glycine backbone for PNA.
24
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CHAPTER III – EXPERIMENTAL SECTION 
Four-way DNA junction assay 
The four oligonucleotides for J1 were purchased from Integrated DNA Technologies 





Oligonucleotide 101 was labeled with fluorescein. Fluorescein labeled strands (101 or 
103) were purified via HPLC (IDT).  Non-labeled strands were purified via denaturing 
polyacrylamide gels (IDT). The four-way DNA junction was prepared by mixing the 101 
labeled strand at 25 µM with the other three non-labeled strands at 5:1 excess (125 µM) 
molar ratio. By making the 101 labeled strand the limiting factor we can therefore 
assume that 100% of the detectable junction is formed at 25 µM.  
Figure 9: Schematic of the four-way DNA junction with 
the 101 strand labeled with fluorescein at the 5’ end. 
The use of a small molecule to improve the thermostability of DNA junctions 13 
13 
 
The strands are then annealed at room temperature in 50 mM Tris-HCl (pH 7.5) and 10 
mM MgCl2, in the absence of light at variable times, to allow the single strands to base-
pair with the complementary adjacent strands to form the junction. 
 
 
Figure 10: Steps for preparing 4WJ. 
 
After the annealing step, 2 μL of each junction sample with compound are mixed with 6 
μL nuclease free water, and incubated with 2 μL reaction buffer (125 mM Tris-HCl, 500 
mM Nacl, 5 μM MgCl2, 20% glycerol, pH 8.0) on ice for 30 minutes, before loading onto 
polyacrylamide gel electrophoresis (PAGE) gels. Electrophoretic mobility shift assays 
(EMSAs) are carried out with the resulting junctions using a Bio-Rad Mini-PROTEAN® 
Tetra Cell system with 15% polyacrylamide gel for 1 – 5 hours at 50 V in 4° C. The 
running buffer was 0.5 x TBE (45 mM Trisma, 45 mM boric acid, and 1.0 M EDTA), pH 
8.0, with 1 μM MgCl2 present in solution. After the gels are run, they are dried on 
Whatman 3MM paper and visualized using a Typhoon 9400 Phosphorimager. Labeled 
single strand is included in the assays as control. 
101 5’-FL1 
(labeled) 
104 103 102 DNA strands: 
4WJ 
Annealing Annealing step: 
DNA Junction: 
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DNA-PNA hybrid junctions:  
PNA strands were incorporated into the junction by replacing the DNA strand at the 
desired position with the complementary PNA strand. Different combinations of DNA-PNA 
hybrids can be achieved by modifying which PNA strand is incorporated into the mixture. 
4WJ-PNA1 was composed of PNA1: H-CAATCCTGAGCA-K-NH2 and oligonucleotides 102, 
103 and 104.   In this case, the labeled strand 103 was mixed with 5-fold excess of 
unlabelled PNA1, 102 and 104. 4WJ-PNA3 was composed of PNA3: H-ATTCGGACTATG-K-
NH2, 101, 102 and 104.  In this case, the labeled strand 101 was mixed with 5-fold excess 
of unlabelled 102, PNA3 and 104. The mobility of the hybrid 4WJ in the EMSAs was 
compared to that of the all-DNA 4WJ, as well as a labeled 101 single strand. 
To perform EMSAs with 4WJ in the presence of small molecules, the small 
molecules are prepared by dissolving the crystals in water at various concentrations. 
Dilutions are prepared in nuclease-free water or annealing buffer containing MgCl2. The 
small molecules are then added to the 4WJ mixture before the annealing step. The 
resulting mixture is run on PAGE gels under the same conditions as before. 
Figure 11: General schematic for 
polyacrylamide gel electrophoresis. 
©Bio-Rad 





Junction assays in the presence of small molecules: 
A series of compounds available for purchase from Sigma-Aldrich™ were tested 
for their binding capacity with 4WJ. The compounds were chosen for their commercial 
availability, known DNA binding motifs (polycyclic, aromatic, and planar), and the 
reported solubilities in water (based on Ksp values).  
  
101 102 103 104 
10 µL 










4WJ-PNA3 4WJ-PNA1,3 4WJ-PNA1 
Figure 12: Preparation of DNA-PNA hybrids. The red strands are PNA strands, and the black is 
labeled DNA, and the blue is unlabeled DNA. Shown here is the stacked-x form of the 4WJ. 
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Table 1: Initial set of compounds obtained from Sigma-Aldrich™:  



















Compound D N,N'-Bis-trityl-hexane-1,6-diamine 
 
 
In spite of the reported Ksp values, the compounds were very difficult to dissolve in Tris 
buffer or water at room temperature, so the above set of compounds were not used for 
further experiments. 
Another molecule was obtained from Dr. Alvin Holder at The University of 
Southern Mississippi. The molecule, [Ru(bpy)2(dpp)PtCl2]Cl2, or Ru(bpy)2 (Figure 6) is 
The use of a small molecule to improve the thermostability of DNA junctions 17 
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The Beer-Lambert Law: 
A = ε × l × c 
Where A is absorbance, 
 ε is molar absorptivity in L mol-1 cm-1 
 l is the path length, in cm, of the cuvette 
  containing the sample 
 c is the concentration of the compound 
 in solution, in mol L-1 
used because of its structural similarities with other known DNA binding substrates, and 
its high solubility in water. 
 
Figure 13: Structure of the Ru(byp)2 molecule. 
 
UV-Vis analysis of [Ru(bpy)2(dpp)PtCl2]Cl2: 
The Ru(bpy)2 compound is characterized via 
ultraviolet and visible wavelength emission 
spectroscopy (UV-Vis) to find absorption 
peaks. For UV-Vis, the Ru(bpy)2 samples are 
prepared in annealing buffer and/or water, at varying concentrations in the nanomolar 
range. The samples are then placed in a cuvette with a path length of 1 cm. Scans were 
run for a wavelength range of 200 nm to 600 nm on a GE Ultrospec 8000. Using the 
Beer-Lambert Law the maximum absorbance peaks of Ru(byp)2 can be determined. 
Once the absorbance peaks of Ru(byp)2 are known, they can be compared against 
substrates of the molecule – in this case DNA junction – to observe binding between the 
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4WJ and Ru(byp)2. To incorporate the Ru(byp)2 molecule into the 4WJ mixture, the 
molecule is dissolved in nuclease-free water and/or annealing buffer, and added before 
the annealing step. 
HMGB1 expression and purification: 
HMGB1b and HMGB1b/R26A from rat were expressed from pHB1-Escherichia 
coli Bl21(DE3)pLysS. Each protein was purified via FPLC using an Econo-Pac CM cartridge 
(Bio-Rad). Crude proteins were loaded onto the CM cartridge in the presence of low salt 
buffer: 50 mM Tris-HCl (pH 7.0), 50 mM NaCl and eluted with high salt buffer 50 mM 
Tris-HCl (pH 7.0), 500 mM NaCl using a linear gradient. Human histone H1 was 
purchased from New England Biolabs. The purity of each protein was monitored by 
resolution of each sample on 12% SDS-polyacrylamide (29:1 acrylamide:bisacrylamide) 
gels in Tris-Tricine buffer (150 V for 45 minutes) followed by staining for 12 hours with 
Coomassie Brilliant Blue G-250. 
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CHAPTER IV – RESULTS AND DISCUSSION 
 
Electrophoretic mobility shift assays (EMSA) of J1 and PNA-DNA hybrid junctions: 
All gels were scanned using a Typhoon 9400 Phosphorimager. 
 
Figure 14 shows an EMSA of the all-DNA junction J1 loaded next to two PNA-DNA 
hybrids: 4WJ-PNA1, and 4WJ-PNA3. The dark bands show the mobility of the junctions 
down the gel. Lane 1 contains a labeled 101 single-strand control that has a high 
mobility compared to the junctions due to its relatively smaller size. It is important to 
note that the all-DNA J1 and the two PNA-DNA hybrids have the same mobility through 
the native gel. This gel data allows us to presume that DNA 4WJ and hybrid 4WJ can 
thus be examined using EMSAs and their binding properties can be compared with one 
another. 
Figure 14: 15% Native gel of 50 nM DNA and hybrid PNA-DNA 4WJs. Lane 1: 
101 single-strand control, lane 2 and 5: J1, lane 3: 4WJ-PNA1, lane 4: 4WJ-PNA3. 
1       2       3       4        5 
J1 J1 





Figure 15 shows EMSAs of J1 and two PNA-DNA hybrids binding with increasing 
concentrations of HMGB1 b-box. Figure 15A shows J1 in the presence of HMGB1b, 15B 




Figure 15: Native EMSAs of 4WJs and HMGB1b. Lane 1: 50 nM 4WJ, lanes 2 – 11; J1 + HMGB1b at 
protein : junction molar ratios of:  1:1, 2:1, 4:1, 8:1, 16:1, 32:1, 64:1, 128:1, 256:1, and 478:1. 
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protein : junction molar ratios of 128:1, 256:1, and 478:1, the hybrid junctions show 
high binding affinities to HMGB1b that are comparable to the all DNA J1. For 4WJ-PNA3, 
the bands at 32:1 and 64:1 molar ratios appear to be stronger than that of J1, suggesting 
a slightly better binding to the protein. 
Once the stability of the PNA-DNA hybrid junctions was established, the 
junctions were tested for thermostability. EMSAs were performed by annealing the 
junctions at elevated temperatures (37°C and 57°C).  
 
Figure 16 shows an assay with 4WJ-PNA1,3 after annealing at 37°C and 57°C. The 
junctions do not maintain their integrity at elevated temperatures. Further studies are 
required with other combinations of PNA-DNA hybrids, as well as three-way DNA 
junctions. 
Figure 16: Native gel of 50 nM 4WJ-PNA1,3, 15% PAGE gel run with 0.5X TBE buffer at 4° C for 90 minutes. 
1) 101 ss control 
2) 4WJ-PNA1,3 – 4°C 10 mM MgCl2   
3) 4WJ-PNA1,3 – 4°C 50 mM NaCl  
4) 4WJ-PNA1,3 – RT 10 mM MgCl2 
5) 4WJ-PNA1,3 –  RT 50 mM NaCl  
6) 4WJ-PNA1,3 – 37°C 10 mM MgCl2 
7) 4WJ-PNA1,3 – 37°C 50 mM NaCl  
8) 4WJ-PNA1,3 – 57°C 10 mM MgCl2 
9) 4WJ-PNA1,3 – 57°C 50 mM NaCl 
1       2        3          4        5          6        7         8        9 




Figure 17: Native gel of J1 samples at 50 nM, run at 4° C (2 hrs) on a 15% native gel. Lanes 1 and 
7 are nucleic acid markers, lanes 2 and 8 are the single strand control. Lanes 3 - 6 and 9 
contained J1 samples annealed via SpeedVac with increasing concentrations of Ru(bpy)2 added, 
and lanes 10 - 13 contain J1 that had been annealed at room temperature in the presence of 
increasing concentrations of Ru(bpy)2: 1.0 nM, 10 nM, and 100 nM. 
Figure 17 shows an EMSA with J1, the all-DNA junction, annealed in the presence of 
Ru(bpy)2. Lanes 3 – 6 contain J1 that has been prepared via SpeedVac and lanes 10 – 13 
contain J1 that was annealed at room temperature, both in the presence of increasing 
concentrations of Ru(bpy)2. The dark bands at the top of the gel are due to junction 
formation. The gel shows that even at nanomolar concentrations of Ru(bpy)2, the 
junction formation is comparable to J1 without any Ru(bpy)2 present. However, J1 
annealed at room temperature was not efficient and could not be elucidated very well, 
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To improve detection of the sample, the assay was repeated for the samples at room 
temperature, but with a higher concentration of J1. Figure 11 shows J1 at 10x higher 
concentration than the one in Figure 10. As a result, the bands can be much better 
elucidated. The dark bands suggest that J1 forms in the presence of Ru(byp)2 at 1.0 nM, 
10 nM, and 100 nM concentrations(lanes 3 – 5 and 8 – 10) , and with relatively better 
efficiency than just the J1 without Ru(byp)2 (lanes 2 and 7).  
  
Figure 18: Native gel of J1 at 500 nM, same conditions as before. Lanes 1, 
6, and 11 are the 101 ss controls; lanes 2 and 7 are J1 without Ru(byp)2; 
and lanes 3 - 5 and 8 - 10 are J1 with 1.0 nM, 10 nM, and 100 nM Ru(byp)2. 
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CHAPTER V – CONCLUSION 
Our data shows that a Ru(byp)2 can effectively assist the assembly of native and 
hybrid junctions in the presence of MgCl2.  This is a significant achievement because one 
of the long-term goals of this project is to use DNA junctions to target the 
proinflammatory cytokine HMGB1.  Prior research10 has clearly shown that hybrid 4WJs 
can be constructed and these molecules bind to HMGB1b and the DNA biding protein 
Histone H1 with high affinity.  More recently, research has shown that the hyrbrid 4WJ, 
4WJ-PNA1,3 posseses enhanced resistance to endo- and exonucleases.  Moreover, the 
hybrids 4WJ-PNA1 and 4WJ-PNA3 possess enhanced stability in fetal bovine serum (FBS) 
vs. J1.  The in vitro and serum stablity data are very encouraging but the thermostabilty 
all 4WJs tested do not exceed 42oC (data not shown).  We presume that enhanced 
levels of thermostabilty will required for the use of these molecules as therapeutics.  
Our initial investigations show that Ru(bpy)2 is capable of forming stable 4WJ and three-
way (3WJs) at room temperature.  This data correlate with those from Howell et al.20  
A similar approach was used by Grueso et. al.23, in which they used a phenanthroline-
derived ruthenium complex to bind to DNA via intercalation. Their data showed that 
Ru(byp)2 enhanced the thermostabilty of calf thymus DNA by > 15
oC.  Based on this, we 
presume that Ru(byp)2 may enhance the stability of native and hybrid 4WJs.  Preliminary 
EMSA data indicates that Ru(bpy)2 does not significantly enhance the stability of the 
hybrid 4WJ-PNA1,3  (Figure 16).  The EMSA data is very informative but these assays do 
not provide an accurate measurement of the thermostability of nucleic acids.  Hence, 
circular dichroism (CD) and UV spectroscopy will be used for future investigations of 
thermostability. 
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